As of the close on October 7, 2026, ENLIE Pharmaceutical JSC's stock has declined approximately 22.73% over the past 52 weeks. The 50-day moving average sits at 10,072.00, while the 200-day moving average is 10,337.00.
| 52-Week Price Change | -22.73% |
| 50-Day Moving Average | 10,072.00 |
| 200-Day Moving Average | 10,337.00 |
Already premium?